Blood test screens 120 fetal genetic disorders
Cambridge University has developed a non-invasive blood test capable of detecting over 120 genetic disorders in the fetus with an accuracy exceeding 99%. The test can be performed starting from the tenth week of pregnancy. It relies on cell-free fetal DNA analysis using artificial intelligence algorithms, offering an affordable price and quick results within five days, while also reducing the risk of miscarriage. It is expected to obtain regulatory approval by the end of 2027 for use in preventive healthcare.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)